.[J] Chinese Pharmaceutical Journal, 2011,V46(9): 707-709
��
[1]
WEHNER T�� BAUER S�� HAMER H M�� et al. Six months of postmarketing experience with adjunctive lacosamide in patients with pharmacoresistant focal epilepsy at a tertiary epilepsy center in Germany[J]. Epilepsy Behav�� 2009�� 16(3��423-425.[2] PERUCCA E�� FRENCH J�� BIALER M. Development of new antiepileptic drugs�� challenges�� incentives�� and recent advances[J]. Lancet Neurol�� 2007�� 6(9��793-804.[3] POLLARD J R�� FRENCH J. Antiepileptic drugs in development[J]. Lancet Neurol�� 2006�� 5(12��1064-1067.[4] ST��HR T�� KUPFERBERG H J�� STABLES J P�� et al. Lacosamide�� a novel anti-convulsant drug��shows efficacy with a wide safety margin in rodent models for epilepsy[J]. Epilepsy Res�� 2007�� 74(2-3��147-154.[5] HAO J X�� ST��HR T�� SELVE N�� et al. Lacosamide a new anti-epileptic�� alleviates neuropathic pain-like behaviors in rat models of spinal cord or trigeminal nerve injury[J]. Eur J Pharmacol�� 2006�� 553(1-3��135-140.[6] BEYREUTHER B�� CALLIZOT N�� ST��HR T. Antinociceptive efficacy of lacosamide in a rat model for painful diabetic neuropathy[J]. Eur J Pharmacol�� 2006�� 539(1-2��64-70.[7] ROGAWSKI M A. Diverse mechanisms of antiepileptic drugs in the development pipeline[J]. Epilepsy Res�� 2006�� 69(3��273-294.[8] ERRINGTON A C�� COYNE L�� ST��HR T�� et al. Seeking a mechanism of action for the novel anticonvulsant lacosamide[J]. Neuropharmacology�� 2006�� 50(8��1016-1029.[9] DIB-HAJJ S D�� BINSHTOK A M�� CUMMINS T R�� et al.Voltage-gated sodium channels in pain states�� Role in pathophysiology and targets for treatment[J]. Brain Res Rev�� 2009�� 60(1��65-83.[10] BHATTACHARYA A�� WICKENDEN A D�� CHAPLAN S R. Sodium channel blockers for the treatment of neuropathic pain[J]. Neurotherapeutics�� 2009�� 6(4��663-678.[11] BEE L A�� DICKENSON A H .Effects of lacosamide�� a novel sodium channel modulator�� on dorsal horn neuronal responses in a rat model of neuropathy[J]. Neuropharmacology�� 2006�� 57(4��472-479.[12] DUNCAN G E�� KOHN H. The novel antiepileptic drug lacosamide blocks behavioral and brain metabolic manifestations of seizure activity in the 6 Hz psychomotor seizure model[J]. Epilepsy Res�� 2005�� 67(1-2��81-87.[13] DOTY P�� RUDD G D�� STOEHR T�� et al. Lacosamide[J]. Neurotherapeutics�� 2007�� 4(1��145-148.[14] BIALER M�� JOHANNESSEN S I�� LEVY R H�� et al. Progress report on new antiepileptic drugs�� A summary of the ninth eilat conference (EILAT IX [J]. Epilepsy Res�� 2009�� 83(1��1-43.[15] SHAIBANI A�� FARES S�� SELAM J L�� et al. Lacosamide in painful diabetic neuropathy�� An 18-week double-blind placebo-controlled trial[J]. J Pain�� 2009�� 10(8��818-828.[16] SCHMIDT D. Drug treatment of epilepsy�� Options and limitations[J]. Epilepsy Behav�� 2009�� 15(1��56-65.
2011, Vol. 46 
